Taniguchi, Yoshinori http://orcid.org/0000-0002-8621-7790
Nishikawa, Hirofumi http://orcid.org/0000-0002-0104-8538
Yoshida, Takeshi http://orcid.org/0000-0003-3951-4618
Terada, Yoshio http://orcid.org/0000-0002-2578-5575
Tada, Kurisu http://orcid.org/0000-0002-6450-1993
Tamura, Naoto http://orcid.org/0000-0003-1729-2954
Kobayashi, Shigeto http://orcid.org/0000-0002-1939-3380
Article History
Received: 25 March 2021
Accepted: 24 April 2021
First Online: 1 May 2021
Declarations
:
: YT (Y Taniguchi) has received speaker fees from AbbVie, Eli-Lilly, and Novartis. KT has received speaker fees and/or consulting fees from AbbVie, Eisai, Eli-Lilly, Janssen, Kyowa Kirin, Mitsubishi-Tanabe, and Novartis. NT has received speaker fees and/or consulting fees from AbbVie, Astellas, Bristol-Myers Squibb, Eisai, Eli-Lilly, Janssen, Kyowa Kirin, Mitsubishi-Tanabe, and Novartis.
: This article does not contain any studies with human participants or animals performed by any of the authors.